Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified